BBLG
Bone Biologics·NASDAQ
--
--(--)
--
--(--)
BBLG fundamentals
Bone Biologics (BBLG) released its earnings on Aug 14, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -1.33 (YoY -98.51%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-1.33
-98.51%
Report date
Aug 14, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Bone Biologics (BBLG) key financial stats and ratios, covering profitability, financial health, and leverage.
Bone Biologics (BBLG)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Bone Biologics (BBLG)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Bone Biologics (BBLG)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Bone Biologics (BBLG) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Bone Biologics (BBLG) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Bone Biologics do and what are its main business segments?What factors drove the changes in Bone Biologics's revenue and profit?What were the key takeaways from Bone Biologics’s earnings call?What is the market's earnings forecast for Bone Biologics next quarter?What is the revenue and EPS growth rate for Bone Biologics year over year?What guidance did Bone Biologics's management provide for the next earnings period?Did Bone Biologics beat or miss consensus estimates last quarter?What is Bone Biologics's latest dividend and current dividend yield?
